JMP Securities Downgrades Intercept Pharmaceuticals (ICPT) to Market Perform
Tweet Send to a Friend
JMP Securities downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from Market Outperform to Market Perform.Analyst Liisa ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
